With understanding of immune function advancing in leaps and bounds and a continuing proliferation of tools to manipulate it, expectations are high for advances in oncology and immunology over the coming year. Biopharma industry executives surveyed by Scrip also flagged up rare diseases, neurology and – of course – COVID-19 as hot areas to watch in 2022.
Jason Bernstein, director and head of medical communications strategy at medical information app provider epocrates, flagged up two key trends...
